Yayang Duan

Dr. Yayang Duan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 August 2023 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
QMQianqing Ma
Qianqing Ma
XLXiaofeng Lu
Xiaofeng Lu
XQXiachuan Qin
Xiachuan Qin
XXXiangyi Xu
Xiangyi Xu
MFMin Fan
Min Fan
CZCaoxue Zhang
Caoxue Zhang

27 December 2023 in Medical Ultrasonography
Verified
Journal Article
Closed access
PDF file
DZDi Zhang
Di Zhang
XZXian-Ya Zhang
Xian-Ya Zhang
YDYayang Duan
Yayang Duan
CDChristoph Frank Dietrich
Christoph Frank Dietrich
XCXinwu Cui
Xinwu Cui
CZCaoxue Zhang
Caoxue Zhang
Over the past few years, developments in artificial intelligence (AI), especially in radiomics and deep learning, have enabled the extraction of pathophysiology-related information from varied medical imaging and are progressively transforming medical practice. AI applications are extending into domains previously thought to be accessible only to human experts. Recent research has demonstrated that ultrasound-derived radiomics and deep learning represent an enticing opportunity to benefit preoperative evaluation and prognostic monitoring of diffuse and focal liver disease. This review summarizes the application of radiomics and deep learning in ultrasound liver imaging, including identifying focal liver lesions and staging of liver fibrosis, as well as the evaluation of pathobiological properties of malignant tumors and the assessment of recurrence and prognosis. Besides, we identify important hurdles that must be overcome while also discussing the challenges and opportunities of radiomics and deep learning in clinical applications.


14 August 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
YZYiqing Zhang
Yiqing Zhang
YDYayang Duan
Yayang Duan
FHFang He
Fang He
CDChunhua Duan
Chunhua Duan
JWJunli Wang
Junli Wang
YZYi Zhou
Yi Zhou
Background: It is difficult to make a definite diagnosis of borderline epithelial ovarian tumors before surgery. In order to avoid incorrectly classifying tumors as benign, a differential diagnosis model was developed to distinguish between benign and borderline epithelial tumors utilizing multimodal information. Method: A multicenter study was conducted. A retrospective analysis of the transvaginal ultrasonography and clinical data of patients who underwent surgery and received pathological diagnoses of borderline and benign epithelial ovarian tumors was conducted. Both Univariate and multivariate logistic regression analyses were used to develop a diagnostic model for borderline epithelial tumors. The efficacy and feasibility of this model were assessed through examination of training, internal validation, and external test sets. Results: There was a significant difference in D-dimer levels between borderline and benign epithelial tumors. Abnormal CA125, D-dimer, maximum mass diameter > 10 cm, regular and irregular solid portions, and blood flow in the mass were independent risk factors for borderline epithelial ovarian tumors. The diagnostic model was evaluated by the Hosmer–Lemeshow test and demonstrated strong fitting capabilities. ROC curve analysis of the training set, verification set, and external test set confirmed the model’s predictive ability. Conclusions: These independent risk factors may be combined to assess the risk of borderline epithelial ovarian tumors. Our findings will assist novice gynecologic sonographers in distinguishing between benign and borderline epithelial tumors.

23 June 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
SLSiyao Li
Siyao Li
YZYunzhi Zhou
Yunzhi Zhou
WLWanyan Li
Wanyan Li
ALAnsheng Liu
Ansheng Liu
YHYanjun Hu
Yanjun Hu
YDYayang Duan
Yayang Duan
Objectives: This study aimed to develop and validate intra-tumoral and peri-tumoral radiomics models based on dynamic contrast-enhanced ultrasound (CEUS) to preoperatively predict lymph node metastasis (LNM) in thyroid cancer patients with type 2 diabetes. Materials and methods: A total of 203 pathologically confirmed diabetic thyroid cancer patients from three centers were retrospectively included and divided into a training cohort and two external validation cohorts. Radiomics features were extracted from CEUS parameters—time to enhancement (TTE), time to half-peak (TTHP), time to peak (TTP), and washout time (WT). Feature dimensionality reduction was performed using Variance Threshold, SelectKBest, and LASSO regression. Key LNM-related features were screened in the training cohort, and the optimal peri-tumoral region (1 mm vs 2 mm) was determined. Intra-tumoral and peri-tumoral radiomics scores were constructed and integrated into a multivariate logistic regression model. Model performance, calibration, and clinical utility were evaluated across all cohorts. Results: The 2 mm peri-tumoral region yielded a higher AUC than the 1 mm region in all cohorts, with statistical significance in the training cohort and a consistent trend in the external validation cohorts. The combined radiomics model achieved AUCs of 0.930 (95% CI: 0.876–0.964), 0.907 (95% CI: 0.796–0.968), and 0.865 (95% CI: 0.739–0.941) in the training and external validation cohorts. Calibration curves showed good agreement between predicted and actual outcomes, and decision curve analysis demonstrated substantial clinical benefit. Conclusions: The CEUS-based combined radiomics model using intra-tumoral and 2 mm peri-tumoral features provides an effective tool for preoperative LNM prediction in thyroid cancer patients with type 2 diabetes.